ArticleInternational journal of hematology2012

Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study.

Yoshikazu Ito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.